Skip to content

Efficacy of Acupuncture Combined with Intradermal Needle Therapy in Patients with Posterior Circulation Ischemic Vertigo: A Randomized Controlled Trial

Efficacy of Acupuncture Combined with Intradermal Needle Therapy in Patients with Posterior Circulation Ischemic Vertigo: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000378
Enrollment
Unknown
Registered
2026-02-13
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posterior Circulation Ischemia Vertigo

Interventions

Control Group:Conventional drug therapy for posterior circulation ischemia vertigo was administered.
Intervention Group:In addition to the control group's treatment, acupuncture combined with press needles was administered.

Sponsors

Department of Neurology, The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Meets the diagnostic criteria for posterior circulation ischemia vertigo as outlined in the Chinese Expert Consensus on Posterior Circulation : 1) Primary complaints include recurrent transient dizziness and headache, which typically resolve within 24 hours but recur frequently; 2) Imaging examinations indicate insufficient blood supply in the basilar or vertebral arteries; 3) Age = 18 years; 4) Clear consciousness and stable basic vital signs; 5) Good compliance with the study, enabling cooperation with treatment and follow-up procedures.

Exclusion criteria

Exclusion criteria: Exclusion criteria included: Coexisting infarctions in the brainstem, occipital lobe, or other regions; Vertigo caused by intracranial space-occupying lesions, infectious diseases, or other pathological conditions; Individuals with coagulation disorders; Those with metal allergies.

Design outcomes

Primary

MeasureTime frame
Visual Analog Scale;EMS-9 Transcranial Doppler Sonography;

Secondary

MeasureTime frame
Frequency and duration of episodes;Dizziness Handicap Inventory;Hamilton Anxiety Rating Scale ;Hamilton Depression Rating Scale ;30-day readmission rate;

Countries

China

Contacts

Public ContactYixia Zhou

School of Nursing, Guizhou University of Traditional Chinese Medicine

zhouyixia014@gzy.edu.cn15908515850

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Mar 14, 2026